All Stories

  1. “It’s becoming the centre of everything” – a qualitative study using Patient Journey Mapping to examine the impact of social factors on healthcare interactions and disease outcomes for people living with rheumatoid arthritis

    Article • Rheumatology Advances in Practice, October 2026, Oxford University Press (OUP)

    Catherine Hill

  2. Mortality and causes of death in patients with Sjögren disease in Western Australia: a population-based study

    Article • Rheumatology, September 2026, Oxford University Press (OUP)

    Dr Fabien B Vincent, Catherine Hill

  3. What Affects Care Complexity in Rheumatoid Arthritis? An Integrative Review of Complexity Domains and Associated Patient and Health System Outcomes

    Article • The Journal of Rheumatology, July 2026, The Journal of Rheumatology

    Catherine Hill

  4. Impact of socioeconomic status on disability in a longitudinal rheumatoid arthritis cohort

    Article • Internal Medicine Journal, July 2026, Wiley

    Catherine Hill

  5. Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national survey

    Article • Internal Medicine Journal, June 2026, Wiley

    Catherine Hill

  6. Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

    Article • Arthritis Care & Research, February 2026, Wiley

    Catherine Hill

  7. Understanding the patient experience of newly diagnosed giant cell arteritis

    Article • Rheumatology Advances in Practice, January 2026, Oxford University Press (OUP)

    Catherine Hill

  8. Reply to ‘Potential benefit of anticoagulation in Behçet syndrome’

    Article • Nature Reviews Rheumatology, October 2025, Springer Science + Business Media

    Catherine Hill

  9. Green Space Exposure: A New Approach for the Prevention and Control of Rheumatoid Arthritis

    Article • The Journal of Rheumatology, October 2025, The Journal of Rheumatology

    Catherine Hill

  10. Agreement Between Self‐Reported Antirheumatic Medications and Pharmaceutical Claims in an Australian Inflammatory Arthritis Cohort

    Article • ACR Open Rheumatology, October 2025, Wiley

    Catherine Hill

  11. Exploring the relationship between allostatic load and osteoarthritis: a cross-sectional analysis from the North West Adelaide Health Study

    Article • Osteoarthritis and Cartilage Open, September 2025, Elsevier

    Catherine Hill

  12. Consumer Perspectives on the Australian Rheumatology Association Rheumatoid Arthritis Clinical Care Standard

    Article • August 2025, Cold Spring Harbor Laboratory Press

    Catherine Hill

  13. Recommendations for the Use of Disease‐Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review

    Article • Arthritis Care & Research, June 2025, Wiley

    Catherine Hill

  14. Th Cell Phenotypes and Their Correlations with Disease Activity in Patients with Rheumatoid Arthritis

    Article • Journal of Clinical Medicine, June 2025, MDPI AG

    Catherine Hill

  15. Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients

    Article • Rheumatology International, May 2025, Springer Science + Business Media

    Catherine Hill

  16. Arterial and venous thrombosis in systemic and monogenic vasculitis

    Article • Nature Reviews Rheumatology, May 2025, Springer Science + Business Media

    Catherine Hill

  17. Appropriateness of lumbar spine imaging in patients presenting to the emergency department with low back pain in a Western Australian tertiary hospital

    Article • Internal Medicine Journal, January 2025, Wiley

    Catherine Hill

  18. Measuring Patient Experience in Rheumatology Outpatient Care

    Article • International Journal of Rheumatic Diseases, January 2025, Wiley

    Catherine Hill

  19. Area‐Level Socioeconomic Status Impacts Health Care Visit Frequency by Australian Patients With Inflammatory Arthritis: Results From the Australian Rheumatology Association Database

    Article • Arthritis Care & Research, December 2024, Wiley

    Catherine Hill

  20. Navigating high‐cost medicines: summary of the Guiding Principles for the governance of high‐cost medicines in Australian hospitals

    Article • Internal Medicine Journal, September 2024, Wiley

    Catherine Hill

  21. Tocilizumab use in giant cell arteritis: comparing Pharmaceutical Benefits Scheme eligible and ineligible cases in South Australia

    Article • Internal Medicine Journal, July 2024, Wiley

    Catherine Hill

  22. Editorial: Quality use of medicines: who owns it now?

    Article • Australian Prescriber, June 2024, Therapeutic Guidelines Limited

    Catherine Hill

  23. Nursing and allied health workforce in Australian public rheumatology departments is inadequate: a cross-sectional observational study

    Article • Rheumatology International, March 2024, Springer Science + Business Media

    Catherine Hill

  24. Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two‐Year, Multicenter, Double‐Blind,...

    Article • Arthritis & Rheumatology, March 2024, Wiley

    Catherine Hill

  25. Exploring the association between circulating endothelial protein C receptor and disease activity of rheumatoid arthritis in a pilot study

    Article • Rheumatology Advances in Practice, January 2024, Oxford University Press (OUP)

    Catherine Hill

  26. Gout Knowledge: A Survey of Australian Outpatients with Gout

    Article • Open Access Rheumatology Research and Reviews, January 2024, Taylor & Francis

    Catherine Hill

  27. Impact of the COVID‐19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis

    Article • Arthritis Care & Research, December 2023, Wiley

    Catherine Hill

  28. Validation of a patient-reported outcome measure for assessing the impact of giant cell arteritis

    Article • Rheumatology, May 2023, Oxford University Press (OUP)

    Dr Mwidimi Ndosi, Catherine Hill

  29. Bone Marrow Lesions and Magnetic Resonance Imaging–Detected Structural Abnormalities in Patients With Midfoot Pain and Osteoarthritis: A Cross‐Sectional Study

    Article • Arthritis Care & Research, December 2022, Wiley

    Catherine Hill

  30. Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review

    Article • Arthritis Care & Research, November 2022, Wiley

    Catherine Hill

  31. Patient Perspectives of Disease Activity, Medications and Substance Use in People with Fibromyalgia

    Article • Open Access Rheumatology Research and Reviews, May 2022, Taylor & Francis

    Catherine Hill

  32. Patient Perceptions of Physical Activity After a Diagnosis of Giant Cell Arteritis: Analysis of Multinational Qualitative Data

    Article • Arthritis Care & Research, December 2021, Wiley

    Catherine Hill

  33. Cancer in Anti‐Neutrophil Cytoplasm Antibody‐Associated Vasculitis and Polyarteritis Nodosa in Australia: A Population‐Based Study

    Article • ACR Open Rheumatology, December 2021, Wiley

    Catherine Hill

  34. Effect of Atorvastatin on Knee Cartilage Volume in Patients With Symptomatic Knee Osteoarthritis: Results From a Randomized Placebo‐Controlled Trial

    Article • Arthritis & Rheumatology, September 2021, Wiley

    Catherine Hill

  35. Sleep disorders and gout in Australian adults

    Article • BMC Rheumatology, August 2021, Springer Science + Business Media

    Catherine Hill

  36. Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

    Article • Nature Reviews Rheumatology, July 2021, Springer Science + Business Media

    Catherine Hill

  37. Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID‐19 pandemic in Australia

    Article • Internal Medicine Journal, July 2021, Wiley

    Catherine Hill

  38. Healthcare access and attitudes towards telehealth during the early phase of the COVID‐19 pandemic among an Australian cohort with inflammatory arthritis

    Article • Internal Medicine Journal, May 2021, Wiley

    Catherine Hill

  39. Patient Reported Outcomes in Large Vessel Vasculitides

    Article • Current Rheumatology Reports, January 2021, Springer Science + Business Media

    Catherine Hill

  40. Chronic stress and arthritis: a scoping review

    Article • Arthritis Care & Research, December 2020, Wiley

    Catherine Hill

  41. Prevalence, deaths and disability adjusted life years (DALYs) due to musculoskeletal disorders for 195 countries and territories 1990‐2017

    Article • Arthritis & Rheumatology, November 2020, Wiley

    Catherine Hill

  42. Associations of OSA and Nocturnal Hypoxemia with Strength and Body Composition in Community Dwelling Middle Aged and Older Men

    Article • Nature and Science of Sleep, November 2020, Taylor & Francis

    Catherine Hill

  43. Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)

    Article • Osteoarthritis and Cartilage, November 2020, Elsevier

    Catherine Hill

  44. Formation of the Australian and New Zealand Vasculitis Society (ANZVASC) to improve the care of patients with vasculitis in Australia and New Zealand

    Article • Internal Medicine Journal, July 2020, Wiley

    Catherine Hill

  45. Repeat serological testing for anti‐citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis

    Article • Internal Medicine Journal, July 2020, Wiley

    Catherine Hill

  46. Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis

    Article • ACR Open Rheumatology, May 2020, Wiley

    Catherine Hill

  47. Precision Medicine with Leflunomide: Consideration of DHODH Haplotype and Plasma Teriflunomide Concentration can Substantially Modify Outcomes in Patients with Rheumatoid Arthritis

    Article • Arthritis Care & Research, April 2020, Wiley

    Catherine Hill

  48. Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care

    Article • Internal Medicine Journal, February 2020, Wiley

    Catherine Hill

  49. Scleroderma Renal Crisis: Observations from the South Australian Scleroderma Register

    Article • Internal Medicine Journal, February 2020, Wiley

    Catherine Hill

  50. A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis

    Article • Open Access Rheumatology Research and Reviews, August 2019, Taylor & Francis

    Dr Tiffany K Gill, Catherine Hill

  51. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit

    Article • International Journal of Rheumatic Diseases, June 2019, Wiley

    Catherine Hill

  52. Gout, flares, and allopurinol use: a population-based study

    Article • May 2019, Springer Science + Business Media

    Catherine Hill

  53. Diagnosis and management of giant cell arteritis: an Asia-Pacific perspective

    Article • International Journal of Rheumatic Diseases, April 2018, Wiley

    Catherine Hill

  54. Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial

    Article • Osteoporosis International, December 2015, Springer Science + Business Media

    Catherine Hill